EI
ETON icon

EAM Investors’s Eton Pharmaceutcials ETON Stock Holding History

EAM Investors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Buy
158,045
+109,422
+225% +$3.21M 0.51% 81
2026
Q1 		$1.2M Buy
+48,623
New +$850K 0.14% 197
2025
Q4 		– Sell
-52,897
Closed -$1.15M – 300
2025
Q3 		$1.15M Buy
+52,897
New +$878K 0.13% 186
2025
Q2 		– Sell
-77,833
Closed -$1.01M – 271
2025
Q1 		$1.01M Sell
77,833
-17,186
-18% -$260K 0.17% 160
2024
Q4 		$1.27M Sell
95,019
-33,257
-26% -$337K 0.18% 154
2024
Q3 		$770K Buy
+128,276
New +$542K 0.12% 199
2023
Q4 		– Sell
-256,623
Closed -$1.07M – 281
2023
Q3 		$1.07M Buy
+256,623
New +$991K 0.21% 229

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

EAM Investors's ETON Position: Q2 2026 in Review

EAM Investors increased its Eton Pharmaceutcials (ETON) stake by 225% in Q2 2026, buying an estimated $3.21M and bringing the position to 158,045 shares worth $5.72M. The position accounts for 0.51% of the portfolio, ranked #81.

EAM Investors first reported a position in ETON in Q3 2023 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • EAM Investors held 158,045 shares of Eton Pharmaceutcials worth $5.72M as of Q2 2026.
  • EAM Investors bought 109,422 Eton Pharmaceutcials shares in Q2 2026, an estimated $3.21M.
  • Eton Pharmaceutcials made up 0.51% of EAM Investors's portfolio in Q2 2026, its #81 holding.
  • EAM Investors first reported a position in Eton Pharmaceutcials in Q3 2023 and has held it in 7 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.